Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
70.74
+0.36 (0.51%)
At close: Oct 29, 2024, 4:00 PM
71.49
+0.75 (1.06%)
After-hours: Oct 29, 2024, 5:10 PM EDT

Bio-Techne Statistics

Total Valuation

Bio-Techne has a market cap or net worth of $11.22 billion. The enterprise value is $11.49 billion.

Market Cap 11.22B
Enterprise Value 11.49B

Important Dates

The next confirmed earnings date is Wednesday, October 30, 2024, before market open.

Earnings Date Oct 30, 2024
Ex-Dividend Date Aug 19, 2024

Share Statistics

Bio-Techne has 158.67 million shares outstanding. The number of shares has decreased by -0.67% in one year.

Shares Outstanding 158.67M
Shares Change (YoY) -0.67%
Shares Change (QoQ) +0.10%
Owned by Insiders (%) 1.05%
Owned by Institutions (%) 98.74%
Float 156.88M

Valuation Ratios

The trailing PE ratio is 67.37 and the forward PE ratio is 37.89. Bio-Techne's PEG ratio is 3.37.

PE Ratio 67.37
Forward PE 37.89
PS Ratio 9.63
Forward PS 8.90
PB Ratio 5.41
P/FCF Ratio 47.54
PEG Ratio 3.37
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 37.02, with an EV/FCF ratio of 48.67.

EV / Earnings 68.37
EV / Sales 9.91
EV / EBITDA 37.02
EV / EBIT 46.85
EV / FCF 48.67

Financial Position

The company has a current ratio of 3.87, with a Debt / Equity ratio of 0.20.

Current Ratio 3.87
Quick Ratio 2.47
Debt / Equity 0.20
Debt / EBITDA 1.26
Debt / FCF 1.78
Interest Coverage 15.59

Financial Efficiency

Return on equity (ROE) is 8.33% and return on invested capital (ROIC) is 6.24%.

Return on Equity (ROE) 8.33%
Return on Assets (ROA) 5.74%
Return on Capital (ROIC) 6.24%
Revenue Per Employee $380,020
Profits Per Employee $55,106
Employee Count 3,050
Asset Turnover 0.43
Inventory Turnover 2.21

Taxes

In the past 12 months, Bio-Techne has paid $17.58 million in taxes.

Income Tax 17.58M
Effective Tax Rate 9.47%

Stock Price Statistics

The stock price has increased by +18.81% in the last 52 weeks. The beta is 1.27, so Bio-Techne's price volatility has been higher than the market average.

Beta (5Y) 1.27
52-Week Price Change +18.81%
50-Day Moving Average 73.54
200-Day Moving Average 73.38
Relative Strength Index (RSI) 43.82
Average Volume (20 Days) 814,277

Short Selling Information

The latest short interest is 3.60 million, so 2.27% of the outstanding shares have been sold short.

Short Interest 3.60M
Short Previous Month 3.52M
Short % of Shares Out 2.27%
Short % of Float 2.30%
Short Ratio (days to cover) 4.47

Income Statement

In the last 12 months, Bio-Techne had revenue of $1.16 billion and earned $168.07 million in profits. Earnings per share was $1.05.

Revenue 1.16B
Gross Profit 770.45M
Operating Income 245.26M
Pretax Income 232.35M
Net Income 168.07M
EBITDA 310.37M
EBIT 245.26M
Earnings Per Share (EPS) $1.05
Full Income Statement

Balance Sheet

The company has $152.86 million in cash and $419.54 million in debt, giving a net cash position of -$266.68 million or -$1.68 per share.

Cash & Cash Equivalents 152.86M
Total Debt 419.54M
Net Cash -266.68M
Net Cash Per Share -$1.68
Equity (Book Value) 2.07B
Book Value Per Share 13.08
Working Capital 458.04M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $298.98 million and capital expenditures -$62.88 million, giving a free cash flow of $236.10 million.

Operating Cash Flow 298.98M
Capital Expenditures -62.88M
Free Cash Flow 236.10M
FCF Per Share $1.49
Full Cash Flow Statement

Margins

Gross margin is 66.47%, with operating and profit margins of 21.16% and 14.50%.

Gross Margin 66.47%
Operating Margin 21.16%
Pretax Margin 16.02%
Profit Margin 14.50%
EBITDA Margin 26.78%
EBIT Margin 21.16%
FCF Margin 21.76%

Dividends & Yields

This stock pays an annual dividend of $0.32, which amounts to a dividend yield of 0.45%.

Dividend Per Share $0.32
Dividend Yield 0.45%
Dividend Growth (YoY) -50.00%
Years of Dividend Growth n/a
Payout Ratio 30.48%
Buyback Yield 0.67%
Shareholder Yield 1.12%
Earnings Yield 1.50%
FCF Yield 2.10%
Dividend Details

Analyst Forecast

The average price target for Bio-Techne is $80.67, which is 14.04% higher than the current price. The consensus rating is "Buy".

Price Target $80.67
Price Target Difference 14.04%
Analyst Consensus Buy
Analyst Count 9
Revenue Growth Forecast (5Y) 11.34%
EPS Growth Forecast (5Y) 31.73%
Stock Forecasts

Stock Splits

The last stock split was on November 30, 2022. It was a forward split with a ratio of 4:1.

Last Split Date Nov 30, 2022
Split Type Forward
Split Ratio 4:1

Scores

Bio-Techne has an Altman Z-Score of 12.42 and a Piotroski F-Score of 5.

Altman Z-Score 12.42
Piotroski F-Score 5